American Well (NYSE:AMWL – Free Report) had its price target lowered by Morgan Stanley from $1.75 to $1.00 in a report published on Monday, Benzinga reports. The firm currently has an equal weight rating on the stock.
American Well Stock Performance
AMWL opened at $0.51 on Monday. The firm has a market cap of $148.65 million, a P/E ratio of -0.21 and a beta of 0.99. The firm has a 50-day moving average of $0.93 and a 200 day moving average of $1.11. American Well has a fifty-two week low of $0.50 and a fifty-two week high of $2.74.
American Well (NYSE:AMWL – Get Free Report) last released its quarterly earnings data on Wednesday, February 14th. The company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.19) by $0.02. The business had revenue of $70.68 million for the quarter, compared to the consensus estimate of $70.16 million. American Well had a negative net margin of 260.63% and a negative return on equity of 40.19%. The company’s revenue was down 10.8% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.22) earnings per share. Equities research analysts predict that American Well will post -0.7 earnings per share for the current fiscal year.
Insider Buying and Selling at American Well
Institutional Investors Weigh In On American Well
A number of institutional investors and hedge funds have recently modified their holdings of AMWL. Swiss National Bank lifted its holdings in shares of American Well by 16.7% in the first quarter. Swiss National Bank now owns 134,500 shares of the company’s stock worth $566,000 after buying an additional 19,200 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of American Well by 272.5% in the first quarter. JPMorgan Chase & Co. now owns 483,351 shares of the company’s stock worth $2,036,000 after buying an additional 353,598 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of American Well by 1.5% in the first quarter. Bank of New York Mellon Corp now owns 679,534 shares of the company’s stock worth $2,861,000 after buying an additional 10,013 shares in the last quarter. Bank of Montreal Can lifted its holdings in shares of American Well by 19.6% in the first quarter. Bank of Montreal Can now owns 106,670 shares of the company’s stock worth $454,000 after buying an additional 17,477 shares in the last quarter. Finally, MetLife Investment Management LLC increased its position in shares of American Well by 41.5% in the first quarter. MetLife Investment Management LLC now owns 90,861 shares of the company’s stock worth $383,000 after purchasing an additional 26,662 shares during the last quarter. 56.05% of the stock is owned by hedge funds and other institutional investors.
American Well Company Profile
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.
Recommended Stories
- Five stocks we like better than American Well
- Investing in the High PE Growth Stocks
- United Airlines Soars on Earnings Beat
- Compound Interest and Why It Matters When Investing
- J.B. Hunt Hits the Skids: Lower Prices to Come
- How to Most Effectively Use the MarketBeat Earnings Screener
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.